| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.014 | 0.8 |